Literature DB >> 568870

DDAVP in childhood nocturnal enuresis.

T Tuvemo.   

Abstract

A double-blind study of 18 children aged 6--12 years suffering from primary nocturnal enuresis without signs of underlying organic disease is reported. 20 microgram of DDAVP (desamino-D-arginine vasopressin, Minirin) was given intranasally at bedtime. The effect was prompt and satisfactory in 8 children and relatively good in another 8 children. No adverse effects were noted. DDAVP is advocated for temporary use in children with nocturnal enuresis needing immediate help.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 568870     DOI: 10.1111/j.1651-2227.1978.tb16255.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  13 in total

1.  Desmopressin for bed wetting: length of treatment, vasopressin secretion, and response.

Authors:  J H Evans; S R Meadow
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

2.  Long-term treatment of nocturnal enuresis with desmopressin. A follow-up study.

Authors:  U B Knudsen; S Rittig; J P Nørgaard; J B Lundemose; E B Pedersen; J C Djurhuus
Journal:  Urol Res       Date:  1991

Review 3.  Hyponatremia in patients with nocturnal enuresis treated with DDAVP.

Authors:  W L Robson; J P Nørgaard; A K Leung
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

4.  Desmopressin in nocturnal enuresis.

Authors:  M Aladjem; R Wohl; H Boichis; S Orda; D Lotan; S Freedman
Journal:  Arch Dis Child       Date:  1982-02       Impact factor: 3.791

Review 5.  Side effects and complications of treatment with desmopressin for enuresis.

Authors:  W L Robson; A K Leung
Journal:  J Natl Med Assoc       Date:  1994-10       Impact factor: 1.798

6.  Primary nocturnal enuresis and desmopressin treatment: do psychosocial factors affect outcome?

Authors:  R W Dittmann; S Wolter
Journal:  Eur Child Adolesc Psychiatry       Date:  1996-06       Impact factor: 4.785

7.  Comparison of intranasal and oral desmopressin for nocturnal enuresis.

Authors:  A Fjellestad-Paulsen; S Wille; A S Harris
Journal:  Arch Dis Child       Date:  1987-07       Impact factor: 3.791

Review 8.  Comparative tolerability of drug treatment for nocturnal enuresis in children.

Authors:  Dominik Müller; Charles C Roehr; Paul Eggert
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 9.  Drug therapy for nocturnal enuresis. Current treatment recommendations.

Authors:  K Miller; B Atkin; M L Moody
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

10.  Comparison of desmopressin and enuresis alarm for nocturnal enuresis.

Authors:  S Wille
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.